1. Bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study

   • D. Schiffer
   • P. Cavalla
   • L. Chiadò-Piat

   Laboratory Investigation Pages: 101 - 109

2. Infrequency of p53 gene mutations in ependymomas

   • Karen L. Fink
   • Elisabeth J. Rushing
   • Perry D. Nisen

   Laboratory Investigation Pages: 111 - 115

3. Immunohistochemical evaluation of erbB-2 and p53 protein expression in benign and atypical human meningiomas

   • Bruce S. Chozick
   • Deborah L. Benzil
   • Paul W. Finch

   Laboratory Investigation Pages: 117 - 126

4. Reversion of phenotype of endothelial cells in brain tissue around glioblastomas

   • Rui Vaz
   • Nuno Borges
   • Isabel Azevedo

   Laboratory Investigation Pages: 127 - 132

5. Adoptive immunotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrent malignant primary brain tumors

   • Suresh K. Sankhla
   • J. S. Nadkarni
   • S. N. Bhagwati

   Clinical Study Pages: 133 - 140

6. Intra arterial chemotherapy with ACNU and radiotherapy in inoperable malignant gliomas

   • L. Chauveinc
   • M. T. Sola-Martinez
   • J. Chiras

   Clinical Study Pages: 141 - 147

7. Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma

   • Dorcas Fulton
   • Raul Urtasun
   • Peter Forsyth

   Clinical Study Pages: 149 - 155

8. Interstitial chemotherapy with mitoxantrone in recurrent malignant glioma: preliminary data

   • Amerigo Boiardi
   • Andrea Salmaggi
   • Antonio Silvani

   Clinical Study Pages: 157 - 162

9. Association of ⁸² Rubidium and ¹¹C-methionine uptake in brain tumors measured by positron emission tomography

   • Ulrich Roelcke
   • Ernst Radü
   • Klaus Leonhard Leenders

   Clinical Study Pages: 163 - 172

10. Low-grade pure and mixed cerebral astrocytomas treated in the CT scan era

    • J. P. Bahary
    • J. G. Villemure
    • J. Hazel

    Clinical Study Pages: 173 - 177

11. Autologous tumor cell vaccination combined with adoptive cellular immunotherapy in patients with Grade III/IV astrocytoma

    • Frank P. Holladay
    • Teresa Heitz-Turner
    • Gary W. Wood

    Clinical Study Pages: 179 - 189